Roivant Sciences (ROIV) Cash from Investing Activities (2020 - 2026)

Roivant Sciences (ROIV) has 6 years of Cash from Investing Activities data on file, last reported at -$855.8 million in Q4 2025.

• Quarterly Cash from Investing Activities rose 69.87% year-over-year to -$855.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$4.7 billion (down 396.79% YoY) and the FY2026 annual result came in at -$682.3 million, up 61.37% from the prior year.
• Cash from Investing Activities eased to -$855.8 million in Q4 2025, from $120.4 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $5.2 billion in Q4 2023 to a low of -$3.3 billion in Q3 2024.
• A 5-year average of -$165.6 million and a median of -$7.5 million in 2022 frame the typical range for Cash from Investing Activities.
• Annual changes were most pronounced in 2023 — Cash from Investing Activities soared 3392.76% — and 2025, when it tumbled 112409.43%.
• Tracing ROIV's Cash from Investing Activities over 5 years: stood at $309.0 million in 2021, then sank by 151.08% to -$157.8 million in 2022, then soared by 3392.76% to $5.2 billion in 2023, then plunged by 154.66% to -$2.8 billion in 2024, then soared by 69.87% to -$855.8 million in 2025.
• The last three Cash from Investing Activities figures came in at -$855.8 million (Q4 2025), $120.4 million (Q3 2025), and -$1.1 billion (Q2 2025), per Business Quant data.